|
Disease | Cell type(s) | Observed phenotypes | Refs | Treatment |
|
Amyotrophic lateral sclerosis (ALS) | iPSC-derived motor neurons | Motor neurons derived from ALS iPSCs displayed hyperexcitability | [5] | Kv7 channel-activator retigabine reversed MN hyperexcitability |
|
Bipolar disorder | Forebrain hPSNs | Increased AP frequency and amplitude in lithium-responsive and -nonresponsive hPSNs selectively responded to treatments (column 5) | [6] | Li2+ reduced hyperexcitability in hPSNs from Li2+-responsive patients Lamotrigine reduced hyperexcitability in Li2+-nonresponsive hPSNs |
|
Down syndrome | Forebrain hPSNs | Decreased frequency (not amplitude) of spontaneous excitatory and inhibitory synaptic events | [7] | None reported |
|
Dravet syndrome | Forebrain hPSNs | (i) Spike generation impaired in GABAergic neurons | [8] | Phenytoin reduced hyperexcitability |
(ii) Increased sodium currents | [9] |
(iii) Hyperexcitability/spontaneous bursting resembling epileptiform activity | [10] |
|
Huntington’s disease | Forebrain and striatal hPSNs | CAG repeat length-dependent reductions in spiking associated with increased cell death | [11] | None reported |
|
Phelan-McDermid syndrome (22q13 deletion) | Forebrain hPSNs | Selective reduction in amplitude and frequency of spontaneous excitatory postsynaptic currents (excitation-inhibition ratio altered) | [12] | Genetic expression of Shank3 or IGF1 treatment restored EPSCs |
|
Psychiatric disease (ASD/SCZ) (NRXN1 mutants) | Forebrain hPSNs and iNs | Impaired neurotransmitter release; reduced sEPSC frequency upregulation of presynaptic CASK protein | [2] | None reported |
|
Rett syndrome | Glutamatergic hPSNs | Decreased activity-dependent calcium oscillations Reduced frequency and amplitude of spontaneous synaptic currents | [13] | None reported |
|
Spinal muscular atrophy (SMA) | iPSC-derived motor neurons | Hyperexcitability and impaired neurotransmission Greater and lower voltage threshold for spike induction | [14] | Genetic correction reversed phenotypes |
|
Timothy syndrome | Forebrain hPSNs | Increased action potential width Greater elevations of intracellular calcium | [15] | None reported |
|
Williams-Beuren syndrome | Forebrain hPSNs | Reduced AP amplitude and prolonged decay; no effect on other passive/active conductance nor mEPSCs | [16] | None reported |
|